Skip to content

which is more effective labour pain reliever paracetamol or tramadol

Efficacy and safety of intravenous paracetamol versus intramuscular tramadol hydrochloride as intrapartum analgesic: a randomised controlled study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014589
Enrollment
1100
Registered
2018-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Healthy primigravida mothers of age 18 to 35 years without any comorbidities

Interventions

Intervention1: Efficacy and safety of intravenous paracetamol versus intramuscular tramadol hydrochloride: total 200 cases of eligible and consenting women willing to participate in study will be rand

Sponsors

government
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Primigravidae in spontaneous labour 2. Active phase of labour (cervical dilation of =4cm,in the presence of adequate uterine 3 contractions per 10 minutes and each lasting at least for 40 seconds) 3. Maternal age between 18 to 35 years 4. Singleton term pregnancy(37 - 42 weeks of gestation) 5. vertex- presenting fetus

Exclusion criteria

Exclusion criteria: 1. clinical evidence of cephalopelvic disproportion 2. Malpresentation 3. scrred uterus , previous cesarean section, hysterotomy or myomectomy 4.medical disorders associated with pregnancy, especially severe anemia, jaundice, hypertension,diabetes, renal impairment 5. Fetal distress 6. Receiving any regional or parenteral analgesia before recuitment in the study. 7. Known hypersensitoivity to the drug family 8. induced labour

Design outcomes

Primary

MeasureTime frame
Subjective assessment of intrapartum labour pain accordance to visual analouge scaleTimepoint: one year

Secondary

MeasureTime frame
1. duration of labour 2. mode of delivery 3. Maternal adverse effect like nausea, vomitting, respiratory distress, post partum hemorrhage and any other specific adverse effect 4. Fetal adverse effect: APGAR score at 1 and 5 min. , number of neonate requiring admission in NICUTimepoint: February 2018 to February 2019

Countries

India

Contacts

Public ContactRana Mondal

N.R.S Medical college and hospital kolkata

pickluchaudhuri@gmail.com8777630801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026